Table 5 Comparison of the presence or absence of ascites and adverse events.
All (n = 51) | With ascites (n = 26) | Without ascites (n = 25) | p | |||||
|---|---|---|---|---|---|---|---|---|
All | Grade3 or more | All | Grade3 or more | All | Grade3 or more | All | Grade3 or more | |
Neutropenia | 33 (65%) | 21 (41%) | 19 (73%) | 13 (50%) | 14 (56%) | 8 (32%) | 0.7712 | 0.7793 |
Anemia | 10 (20%) | 5 (10%) | 8 (31%) | 3 (12%) | 2 (8%) | 2 (8%) | 0.0751 | 0.3497 |
Platelet decreased | 3 (6%) | 1 (2%) | 2 (8%) | 1 (4%) | 1 (4%) | 0 | 1 | 1 |
Febrile neutropenia | 4 (8%) | 4 (8%) | 3 (12%) | 3 (12%) | 1 (4%) | 1 (4%) | 0.6098 | 0.6098 |
Peripheral sensory neuropathy | 21 (42%) | 0 | 8 (31%) | 0 | 13 (52%) | 0 | 0.1599 | |
Fatigue | 15 (30%) | 0 | 8 (31%) | 0 | 7 (28%) | 0 | 0.7544 | |
Anorexia | 9 (20%) | 1 (2%) | 6 (23%) | 1 (4%) | 3 (12%) | 0 | 0.0751 | 1 |
Stomatitis | 5 (10%) | 1 (2%) | 4 (15%) | 1 (4%) | 1 (4%) | 0 | 0.1104 | 1 |
Bleeding | 5 (10%) | 0 | 3 (12%) | 0 | 2 (8%) | 0 | 0.6098 | |
Edema | 2 (4%) | 0 | 1 (4%) | 0 | 1 (4%) | 0 | 1 | |
Proteinuria | 3 (6%) | 3 (6%) | 3 (12%) | 3 (12%) | 0 | 0 | 0.2353 | 0.2353 |
Hypertension | 2 (4%) | 1 (2%) | 2 (8%) | 0 | 2 (8%) | 1 (4%) | 0.1104 | 0.4902 |
Infection | 3 (6%) | 2 (4%) | 1 (4%) | 0 | 1 (4%) | 0 | 1 | 1 |
